Business Wire

IL-AIT-WORLDWIDE

28.8.2024 17:04:29 CEST | Business Wire | Press release

Share
AIT Worldwide Logistics Launches New AI and Data Science Team

Global supply chain solutions leader, AIT Worldwide Logistics, is pleased to announce the launch of its new artificial intelligence (AI) and data science team, a corporate-level department created to amplify the organization’s investment in data. The team will set the stage for the future implementation of next-generation AI tools to further enhance the company’s robust customer interface. To lead the new group, AIT’s Patrick Chew has been appointed to vice president, AI and data science.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240828389373/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Data is an integral pillar at AIT, with the new AI and data science team working to enable a new era of dramatic growth for the company. (Photo: Business Wire)

“AIT is continually looking towards the future,” said Chairman and Chief Executive Officer, Vaughn Moore. “With the establishment of the AI and data science team, the company is prepared to capitalize on generative AI, natural language processing, machine learning, large language models, and other advancing technologies.”

Over the course of 25 years, Chew has helped numerous Fortune 500 companies improve their business intelligence, analytics, and data enablement. He most recently served as the head of Caterpillar’s enterprise data governance office. Since joining the company in January 2024, Chew has been responsible for directing data enablement efforts. He reports to AIT’s President and Chief Operating Officer, Keith Tholan.

“AIT leadership has made a significant commitment to transform our data, and we are delighted to have Patrick in a role where he can leverage his vast experience to guide our ongoing data journey for the primary benefit of our customers and teammates,” Tholan said.

“Data is a common denominator that informs and impacts every aspect of the business,” he added. “And at AIT, our investment in taking data enablement to the next level clearly signals that data is an integral pillar of the organization, with the new AI and data science team working to enable a new era of dramatic growth for the company.”

The AI and data science group is comprised of three key teams:

  • Data enablement – leading a disciplined, firmwide process to reorganize existing data strongholds into next-gen-compatible assets that will build new levels of trust with stakeholders through increased efficiency and ever-improving solutions
  • AI governance and data science – developing new AI business features with an emphasis on heightened accuracy and privacy protections for customers and teammates as the technology continues to mature and evolve
  • Business intelligence and analytics – providing dedicated, centralized reporting and visualization needs across the organization

The AI and data science team is implementing a regimented approach to transform data across AIT’s global network, including steps to redefine core domains and enhance time-tested workflows. Data management based on a newly configured single version of truth will be well-positioned to support powerful new key performance indicators.

“Treating data as an asset involves rigorous efforts to reorganize and harness millions of inputs, which will be applied in meaningful ways to enhance business intelligence, boost efficiency and spur innovation,” Chew said.

“Ambitiously raising the bar to loftier heights for data quality and governance ultimately improves outcomes for stakeholders as we continue to earn our customers’ trust,” he added. “Our AI and data science initiative will further differentiate AIT with shippers and investors when compared to others in the freight forwarding industry.”

About AIT Worldwide Logistics

AIT Worldwide Logistics is a global freight forwarder that helps companies grow by expanding access to markets all over the world where they can sell and/or procure their raw materials, components and finished goods. For more than 40 years, the Chicago-based supply chain solutions leader has relied on a consultative approach to build a global network and trusted partnerships in nearly every industry, including aerospace, automotive, consumer retail, energy, food, government, high-tech, industrial, life sciences and marine. Backed by scalable, user-friendly technology, AIT’s flexible business model customizes end-to-end deliveries via sea, air, ground and rail — on time and on budget. With expert teammates staffing more than 150 worldwide locations in Asia, Europe and North America, AIT’s full-service options also include customs clearance, warehouse management and white glove services. Learn more at www.aitworldwide.com.

Our Mission

At AIT, we vigorously seek opportunities to earn our customers’ trust by delivering exceptional worldwide logistics solutions while passionately valuing our co-workers, partners and communities.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828389373/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release

Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d

Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release

Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L

Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release

New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel

HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 17:30:00 CEST | Press release

HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye